| Record Information |
| Version |
3.5 |
| Creation Date |
2007-04-12 17:22:02 -0600 |
| Update Date |
2013-02-08 17:14:32 -0700 |
| HMDB ID |
HMDB06112 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Malondialdehyde |
| Description |
Malondialdehyde (MDA) is the dialdehyde of malonic acid and a biomarker of oxidative damage to lipids caused by smoking. Oxidized lipids are able to produce MDA as a decomposition product. The mechanism is thought to involve formation of prostaglandin-like endoperoxides from polyunsaturated fatty acids with two or more double bonds. An alternative mechanism is based on successive hydroperoxide formation and β-cleavage of polyunsaturated fatty acids. MDA is then directly formed by β-scission of a 3-hydroperoxyaldehyde or by reaction between acrolein and hydroxyl radicals. While oxidation of polyunsaturated fatty acids is the major source of MDA in vivo, other minor sources exists such as byproducts of free radical generation by ionizing radiation and of the biosynthesis of prostaglandins. Aldehydes are generally reactive species capable of forming adducts and complexes in biological systems and MDA is no exception although the main species at physiological pH is the enolate ion which is of relative low reactivity. Consistent evidence is available for the reaction between MDA and cellular macromolecules such as proteins, RNA and DNA. MDA reacts with DNA to form adducts to deoxyguanosine and deoxyadenosine which may be mutagenic and these can be quantified in several human tissues. Oxidative stress is an imbalance between oxidants and antioxidants on a cellular or individual level. Oxidative damage is one result of such an imbalance and includes oxidative modification of cellular macromolecules, induction of cell death by apoptosis or necrosis, as well as structural tissue damage. Chemically speaking, oxidants are compounds capable of oxidizing target molecules. This can take place in three ways: abstraction of hydrogen, abstraction of electrons or addition of oxygen. All cells living under aerobic conditions are continuously exposed to a large numbers of oxidants derived from various endogenous and exogenous sources. The endogenous sources of oxidants are several and include the respiratory chain in the mitochondria, immune reactions, enzymes such as xanthine oxidase and nitric oxide synthase and transition metal mediated oxidation. Various exogenous sources of ROS also contribute directly or indirectly to the total oxidant load. These include effects of ionizing and non-ionizing radiation, air pollution and natural toxic gases such as ozone, and chemicals and toxins including oxidizing disinfectants. A poor diet containing inadequate amounts of nutrients may also indirectly result in oxidative stress by impairing cellular defense mechanisms. The cellular macromolecules, in particular lipids, proteins and DNA, are natural targets of oxidation. Oxidants are capable of initiating lipid oxidation by abstraction of an allylic proton from a polyunsaturated fatty acid. This process, by multiple stages leading to the formation of lipid hydroperoxides, is a known contributor to the development of atherosclerosis. (PMID: 17336279 ). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 1,3-Propanedial
- 1,3-Propanedialdehyde
- 1,3-Propanedione
- Malonaldehyde
- Malonic aldehyde
- Malonic dialdehyde
- Malonodialdehyde
- Malonyldialdehyde
- MDD
- Propanedial
|
| Chemical Formula |
C3H4O2 |
| Average Molecular Weight |
72.0627 |
| Monoisotopic Molecular Weight |
72.021129372 |
| IUPAC Name |
propanedial |
| Traditional IUPAC Name |
malonaldehyde |
| CAS Registry Number |
542-78-9 |
| SMILES |
O=CCC=O |
| InChI Identifier |
InChI=1S/C3H4O2/c4-2-1-3-5/h2-3H,1H2 |
| InChI Key |
WSMYVTOQOOLQHP-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Aliphatic Acyclic Compounds |
| Class |
Carbonyl Compounds |
| Sub Class |
Aldehydes |
| Other Descriptors |
- Aliphatic Acyclic Compounds
- dialdehyde(ChEBI)
|
| Substituents |
|
| Direct Parent |
Aldehydes |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
Not Available |
| Application |
Not Available |
| Cellular locations |
Not Available |
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
72 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
Not Available
|
| Biological Properties |
| Cellular Locations |
Not Available
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
| Tissue Location |
Not Available
|
| Pathways |
Not Available
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.69 +/- 0.13 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
2.36 +/- 0.55 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
3.85 (1.7 - 8.3) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.22 +/- 0.089 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.002 +/- 0.0002 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.0013 +/- 0.0002 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.32 +/- 0.073 uM |
Not Specified |
Not Specified |
Guillain-Barre syndrome (GBS) |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.22 +/- 0.06 uM |
Not Specified |
Not Specified |
multiple sclerosis |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
5.3 (0.38 - 55.0) uM |
Adult (>18 years old) |
Both |
Parkinson's disease |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Parkinson's disease |
- Shukla R, Rajani M, Srivastava N, Barthwal MK, Dikshit M: Nitrite and malondialdehyde content in cerebrospinal fluid of patients with Parkinson's disease. Int J Neurosci. 2006 Dec;116(12):1391-402.
Pubmed: 17145675
|
| Smoking |
- Li N, Jia X, Chen CY, Blumberg JB, Song Y, Zhang W, Zhang X, Ma G, Chen J: Almond consumption reduces oxidative DNA damage and lipid peroxidation in male smokers. J Nutr. 2007 Dec;137(12):2717-22.
Pubmed: 18029489
|
|
| Associated OMIM IDs |
|
| External Links |
| DrugBank ID |
DB03057  |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB008116 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
10499  |
| KEGG Compound ID |
C19440  |
| BioCyc ID |
Not Available |
| BiGG ID |
Not Available |
| Wikipedia Link |
Malondialdehyde  |
| NuGOwiki Link |
HMDB06112  |
| Metagene Link |
HMDB06112  |
| METLIN ID |
Not Available |
| PubChem Compound |
10964  |
| PDB ID |
MDD  |
| ChEBI ID |
566274  |
| References |
| Synthesis Reference |
Not Available |
| Material Safety Data Sheet (MSDS) |
Not Available
|
| General References |
Not Available
|